Food from CO2
Arkeon Biotechnologies, a Viennese startup, uses gas fermentation technology to convert CO2 into food products
Vienna-based startup Arkeon Biotechnologies has closed its seed funding in an oversubscribed investment round of more than $7 million. Arkeon is the world's first company to use gas fermentation technology from archaea, a microorganism with unique properties, for food applications. The proprietary technology produces all 20 amino acids for human nutrition in a single production step.
The founders of Arkeon Biotechnologies
Arkeon Biotechnologies
Aiming to create a sustainable, nutritious yet ethical food system, Arkeon uses highly efficient microorganisms - archaea - to produce functional and individualized proteins. In doing so, the technology works independently of agricultural land. Both the current scarcity of resources and the geographic limitations and use of animals in agriculture can thus be overcome.
Leading investors from the food and climate sectors, including Synthesis Capital, ReGen Ventures and Square One Foods, participated in the investment round. The secured funding will now be used to expand production, process engineering and product development.
Arkeon's founding was supported by Berlin-based company builder EVIG, which specializes in working with scientists:in building biotechnology startups in the food sector.
"We are proud to work with experienced investors who strongly believe in our vision to produce the next generation of proteins from CO2," explains Dr. Gregor Tegl, co-founder and CEO of Arkeon Biotechnologies.
Arkeon's products are 100% vegan, GMO-free and can be used as clean label ingredients for plant-based foods, nutritional products, beverages, cell culture media for cultured meat and more.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Other news from the department business & finance
These products might interest you
CHOventure Growth Medium by Capricorn Scientific
High-Yield Protein Production with CHO Cells for Biopharmaceutical Applications
Optimized for High-Density Cultures and Enhanced Protein Yields in CHO Cell Bioprocessing
HEK Media by Sartorius
Serum-free cell culture media for HEK cells
Optimised for HEK293 cells and viral vector production, ISO 9001 certified
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.
See the theme worlds for related content
Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.
Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.
